PRLD vs. OXLC

In the year-to-date period, PRLD achieves a -30.52% return, which is significantly lower than OXLC's -1.99% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Prelude Therapeutics Incorporated (PRLD) and Oxford Lane Capital Corp. (OXLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PRLD Sharpe Ratio is -0.63, which is lower than the OXLC Sharpe Ratio of 0.14. The chart below compares the historical Sharpe Ratios of PRLD and OXLC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PRLD has not paid dividends to shareholders, while OXLC's dividend yield for the trailing twelve months is around 23.62%.

The maximum PRLD drawdown since its inception was -99.33%, which is greater than OXLC's maximum drawdown of -74.58%. Use the drawdown chart below to compare losses from any high point for PRLD and OXLC.

Prelude Therapeutics Incorporated (PRLD) has a higher volatility of 31.52% compared to Oxford Lane Capital Corp. (OXLC) at 6.50%. This indicates that PRLD's price experiences larger fluctuations and is considered to be riskier than OXLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Prelude Therapeutics Incorporated and Oxford Lane Capital Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.